The more we read about our treatment of prostate cancer the more it looks like medical shamanism. Now comes a study suggesting that some drugs that have been used to keep prostate cancer in check actually increase the risk of aggressive prostate cancer. The Washington Post reports that the Food and Drug Administration issued a safety alert that a group of drugs called 5-alpha reductase inhibitors — sold under the names Avodart, Proscar, Jalyn and Propecia — may boost the chances of developing “high-grade†prostate cancer. The Post reports that the FDA took the action after reviewing two large studies, which showed that the drugs reduced the overall risk of getting prostate cancer but increased the chances of developing high-grade tumors. The drugs are used to shrink enlarged prostate glands, a condition known as benign prostatic hyperplasia, or BPH. Proscar and Avodart are also approved to reduce the risk of urinary retention or surgery related to an enlarged prostate. Propecia is approved to treat “male pattern†hair loss. The drugs are also known as dutasteride and finasteride. The paper reports that earlier this year the FDA refused a request from both companies to approve the drugs for use in preventing prostate cancer, citing the increased risk for the more serious tumors.
Health, fitness and lifestyle tips for people over 50 who still like to play hard
Sunday, June 1, 2025
Then why did the FDA release it in the first place like alot of durgs that the give there approval of 6 months later the cure is worse than the illness, drugs are being rcalled at a very high rate does the FDA not test these.
Survior
The AMA should require Dr,s to inform all patient’s of these facts.